BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock

Reuters2023-03-24

March 24 (Reuters) - Allarity Therapeutics Inc :

* ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK

* ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES

Source text for Eikon: Further company coverage:

((Reuters.Briefs@thomsonreuters.com;))

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

Aidukas
2023-03-25
Aidukas
Ha ha.... manipulation.. almost I write true!
Aidukas
2023-03-24
Aidukas
Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2321367199?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2023-03-24 18:03","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2321367199","market":"us","top_or_hot":-1,"title":"BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock","media":"Reuters","content":"<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","source":null,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-24 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"SANA","symbol_name":"Sana Biotechnology, Inc.","start_time":0,"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","article_id":"2321367199","we_media_id":"1036604489","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2321367199","pubTimestamp":1679652203,"columns":[],"sourceInfo":null,"weMediaInfo":{"media_name":"Reuters","introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"summary":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"SANA":"Sana Biotechnology, Inc.","BK4023":"应用软件","ONTF":"ON24, Inc.","BK4082":"医疗保健设备","ALLR":"Allarity Therapeutics Inc","BK4139":"生物科技","LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","BK4007":"制药","BK4196":"保健护理服务","CGEM":"Cullinan Therapeutics"},"translate_title":"简要-Allarity Therapeutics宣布普通股反向股票分割","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"SANA":0.9,"ALLR":0.9,"016744203":0.9,"CGEM":0.9,"APR":0.9,"LHDX":0.9,"LABP":0.9,"ONTF":0.9},"content_text":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"0","news_tag":"","news_rank":0,"symbols":[],"gpt_button":0,"need_auth":false,"code":"91000000","status":"200"},"commentList":[{"id":9943793023,"gmtCreate":1679676347262,"gmtModify":1679676354352,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":11,"crmLevelSwitch":1,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"htmlText":"Ha ha.... manipulation..&nbsp; &nbsp;almost I write true!","listText":"Ha ha.... manipulation..&nbsp; &nbsp;almost I write true!","text":"Ha ha.... manipulation.. almost I write true!","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943793023","repostId":2321367199,"repostType":2,"repost":{"id":"2321367199","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1679652203,"share":"https://ttm.financial/m/news/2321367199?lang=en_US&edition=fundamental","pubTime":"2023-03-24 18:03","market":"us","language":"en","title":"BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2321367199","media":"Reuters","summary":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK","content":"<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-24 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SANA":"Sana Biotechnology, Inc.","BK4023":"应用软件","ONTF":"ON24, Inc.","BK4082":"医疗保健设备","ALLR":"Allarity Therapeutics Inc","BK4139":"生物科技","LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","BK4007":"制药","BK4196":"保健护理服务","CGEM":"Cullinan Therapeutics"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2321367199","content_text":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"SANA":0.9,"ALLR":0.9,"016744203":0.9,"CGEM":0.9,"APR":0.9,"LHDX":0.9,"LABP":0.9,"ONTF":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"},{"id":9943454169,"gmtCreate":1679655891751,"gmtModify":1679655896773,"author":{"id":"4133623950260892","authorId":"4133623950260892","name":"Aidukas","avatar":"https://community-static.tradeup.com/news/default-avatar.jpg","vip":1,"hat":"https://static.tigerbbs.com/b0a2963eb37c60c5d6d4a8dbcd266952","crmLevel":11,"crmLevelSwitch":1,"authorIdStr":"4133623950260892","idStr":"4133623950260892"},"htmlText":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]&nbsp;","listText":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]&nbsp;","text":"Thank you very much,you are angels!Just make price 0.05 and split in 35 . Awesome![Cool]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":0,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9943454169","repostId":2321367199,"repostType":2,"repost":{"id":"2321367199","kind":"highlight","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1679652203,"share":"https://ttm.financial/m/news/2321367199?lang=en_US&edition=fundamental","pubTime":"2023-03-24 18:03","market":"us","language":"en","title":"BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock","url":"https://stock-news.laohu8.com/highlight/detail?id=2321367199","media":"Reuters","summary":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK","content":"<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>BRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBRIEF-Allarity Therapeutics Announces Reverse Stock Split Of Common Stock\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2023-03-24 18:03</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p>March 24 (Reuters) - <a href=\"https://laohu8.com/S/ALLR\">Allarity Therapeutics Inc</a>   :</p><p>   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK</p><p>   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARES</p><p>Source text for Eikon:    Further company coverage:   </p><p> ((Reuters.Briefs@thomsonreuters.com;))</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"SANA":"Sana Biotechnology, Inc.","BK4023":"应用软件","ONTF":"ON24, Inc.","BK4082":"医疗保健设备","ALLR":"Allarity Therapeutics Inc","BK4139":"生物科技","LABP":"Landos Biopharma, Inc.","LHDX":"Lucira Health, Inc.","BK4007":"制药","BK4196":"保健护理服务","CGEM":"Cullinan Therapeutics"},"source_url":"http://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2321367199","content_text":"March 24 (Reuters) - Allarity Therapeutics Inc   :   * ALLARITY THERAPEUTICS ANNOUNCES REVERSE STOCK SPLIT OF COMMON STOCK   * ALLARITY THERAPEUTICS INC: INTENDS TO EFFECT A REVERSE STOCK SPLIT OF ITS COMMON STOCK, AT A RATIO OF 1 POST SPLIT SHARE FOR EVERY 35 PRE-SPLIT SHARESSource text for Eikon:    Further company coverage:    ((Reuters.Briefs@thomsonreuters.com;))","news_type":1,"symbols_score_info":{"SANA":0.9,"ALLR":0.9,"016744203":0.9,"CGEM":0.9,"APR":0.9,"LHDX":0.9,"LABP":0.9,"ONTF":0.9}},"isVote":1,"likeStatus":false,"favoriteStatus":false,"reportStatus":false,"tweetType":1,"langContent":"EN"}],"isCommentEnd":false,"newsSizeData":{"likeSize":0,"commentSize":2,"repostSize":2,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.35.12","shortVersion":"4.35.12","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2321367199","isCrawlerRequest":true}